Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for NOVO NORDISK, INC. · Pharmaceutical company

 Filing Registration
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · posted Apr 7, 2026

Official filing document

 Lobbying activity 3
Health Issues

Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.

Medicare/Medicaid

Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.

Trade (domestic/foreign)

Issues related to compounding and counterfeit drugs; drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharamcy benefit management reforms; Most Favored Nation drug pricing; tariffs; importation of counterfeit drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem